U.S. Resumes Free COVID Test Program
THURSDAY, Sept. 21, 2023 (HealthDay News) -- Americans will once again be able to get free at-home COVID tests.
The U.S. Department of Health and Human Services (HHS) announced Wednesday that it will spend $600 million to buy and offer the tests, produced by 12 domestic manufacturers, and it will begin accepting orders for those tests on Monday through covidtests.gov.
“The Biden-Harris Administration, in partnership with domestic manufacturers, has made great strides in addressing vulnerabilities in the U.S. supply chain by reducing our reliance on overseas manufacturing,” HHS Secretary Xavier Becerra said in an agency news release. “These critical investments will strengthen our nation’s production levels of domestic at-home COVID-19 rapid tests and help mitigate the
spread of the virus.”
Households that order will receive four free tests.
This plan will not only get tests in the hands of people in case of another COVID surge, but it will also increase domestic manufacturing capacity, officials noted.
Manufacturers can sell tests directly to retailers, rather than the government, if there is significant demand for them, said Dawn O’Connell, assistant secretary for preparedness and response at the HHS.
The government’s investment will pay for about 200 million tests to replenish the country’s stockpile, the HHS said.
Free tests have been previously offered at other times during the pandemic, including from early 2022 through summer of that year and from late 2022 until the spring of 2023.
The government is also encouraging Americans to get the new COVID boosters.
Becerra received his COVID and flu shots publicly on Wednesday, the New York Times reported.
“I feel comfortable, having gotten the shots, that I could hug and kiss my mother and not be responsible for getting her sick,” Becerra said, adding that, “No one is safe until everyone is safe.”
Becerra’s mom is about to turn 90.
All Americans starting as young as 6 months old should get at least one dose of the new boosters from Pfizer or Moderna, according to the the U.S. Centers for Disease Control and Prevention.
COVID hospitalizations have been increasing, but are low compared to some earlier parts of the pandemic, the Times reported.
More information
The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.
SOURCE: U.S. Department of Health and Human Services, news release, Sept. 20, 2023; New York Times
Related Articles
Search Allergy Articles
Watchdog Group Says U.S. Food Recalls Rose Again Last Year
Food Allergies in College 101: Tips to Cope
FDA Warns Top National Bakery to Stop Listing Allergens in Products When They Aren't There
Gas Stoves Could Leave Your Lungs Vulnerable to Nitrogen Dioxide
Many Primary Care Docs Unaware of Biologic Asthma Meds
FDA Expands Use of Asthma Med Xolair to Treat Food Allergies
American Air Is Getting Cleaner, But Benefits Aren't Reaching All
Asthma Could Raise Miscarriage, Infertility Risks for Women: Study
Flu, COVID Cases Climb as RSV Infections Start to Level Off
Respiratory Illnesses in China Not Caused by New Virus, CDC Director Testifies
Robitussin Honey Cough Syrup Recalled Due to Fungal Threat
ERs Might Be Good Spots to Offer Flu Shots
Texan Has Contracted H5N1 Bird Flu; CDC Calls Threat to Public 'Low'